In line with Bio*One Capital’s investment objective of meeting both financial returns and economic spin-offs to Singapore, we focus on building and growing sustainable companies which have clear paths to products and services. Companies must have exceptional management teams, commercially viable business models, technologies that can be translated to practical applications, excellent market opportunities in a fast-growing market, and clear exit strategy for investors. We also seek areas where we can enhance the value of the companies’ operations, for example through the establishment of a sustainable R&D, and/or manufacturing and/or business operations in Singapore.

In many of our investments, Bio*One Capital plays a lead role and is an active participant in the growth of our portfolio companies. We work closely with the companies to shape their strategies, strengthen corporate governance, build management teams, extend their business global network, and develop pivotal industry relationships.

Geographically, we concentrate our investments into companies based in Singapore, North America, Western Europe and Asia, but will consider investment opportunities in other regions, where there is a well-developed biomedical sciences sector and where Bio*One Capital can add significant value.